Evaluation of the clinical effectiveness of Safetac soft silicone dressings in the management of skin tears

Evaluation of the effect of safetac soft silicone dressings on healing rates of skin tears, and impact on peri-wound skin

Status

Not yet recruiting

Phases

Phase 4

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12606000092594

Enrollment

400

Registered

2006-03-09

Start date

2006-05-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

To objectively evaluate the efficacy of Safetac soft silicone dressings compared with standard treatment, on skin tear healing rates. Also to measure the impact of wound dressings on the surrounding skin. It is expected that a significantly greater proportion of patient skin tears treated with soft silicone will be healed, without trauma to the surrounding skin, at 7 days when compared with the group receiving standard treatment

Interventions

A randomised prospective clinical trial. Safetac soft silicone coated dressings (Mepitel and Mepilex Border) after seven days of treatment.

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

65 Years to No maximum

Healthy volunteers

Inclusion criteria

A skin tear sustained during hospitalisation.

Exclusion criteria

Pre-admission skin tears non-consenting patientspatients with behavioural problems with which may interfere with the wound dressing protocol.

Outcome results